Mirai MRI for High-Risk Breast Cancer Screening
MIRAI-MRI: Comparing Screening MRI for Patients at High Risk for Breast Cancer Identified by Mirai and Tyrer-Cuzick
Recruiting
N/A
Interventional Study
Breast Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 40 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 200 (estimated)
- Sponsor
- University of Massachusetts, Worcester · Other
Who this trial is looking for
This trial is looking for women at high risk for breast cancer to participate in a study comparing a new screening method using MRI. Participants will receive a supplemental MRI scan to help detect breast cancer earlier.
Are You a Good Fit for This Trial?
You may be able to join if
- I am a woman over 40 years old.
- I have been identified as high risk for breast cancer by the Mirai system.
- I have a report of a recent mammogram with available images.
- I can provide reports of all my follow-up mammograms and other studies.
You may not be able to join if
- I am under 40 years old.
- I am currently pregnant.
- I am a male.
- I have had poor quality mammogram images.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Accurate risk assessment is essential for the success of population screening programs and early detection efforts in breast cancer. Mirai is a new deep learning model based on full resolution mammograms.
Mirai is a mammography-based deep learning model designed to predict risk at multiple timepoints, leverage potentially missing risk factor information, and produce predictions that are consisten…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Women who were identified as high risk on the retrospective study (dating from 2017-2025) using MIRAI will be recruited and consented for the prospective study
* Women over 40 years of age identified as high risk according to traditional guidelines will also be potentially eli…
Contacts